TransMontaigne (TLP) Prices 1.45M Offering at $43.32/Unit
Get Alerts TLP Hot Sheet
Join SI Premium – FREE
TransMontaigne Partners L.P. (NYSE: TLP) announced that it has priced an underwritten public offering of 1,450,000 common units representing limited partner interests of the Partnership. The Partnership has granted the underwriters a 30-day option to purchase up to 217,500 additional common units. The common units were offered to the public at $43.32 per unit. In addition, TransMontaigne GP L.L.C., the general partner of the Partnership, is expected to make a proportionate cash contribution to maintain its 2.0% general partner interest in the Partnership. The offering is expected to close on July 24, 2013, subject to customary closing conditions.
The Partnership intends to use a portion of the net proceeds from the offering, including any net proceeds received from an exercise of the underwriters’ option to purchase additional common units, to repay indebtedness outstanding under its senior secured credit facility and to fund a portion of its proportionate share of the construction cost of Battleground Oil Specialty Terminal Company LLC, its joint venture with Kinder Morgan Energy Partners, L.P.
Morgan Stanley, BofA Merrill Lynch, Citigroup and Wells Fargo Securities are acting as joint book-running managers for the offering.
The Partnership intends to use a portion of the net proceeds from the offering, including any net proceeds received from an exercise of the underwriters’ option to purchase additional common units, to repay indebtedness outstanding under its senior secured credit facility and to fund a portion of its proportionate share of the construction cost of Battleground Oil Specialty Terminal Company LLC, its joint venture with Kinder Morgan Energy Partners, L.P.
Morgan Stanley, BofA Merrill Lynch, Citigroup and Wells Fargo Securities are acting as joint book-running managers for the offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Csquare prices IPO at $21 per share, raising $1.01 billion
- Q32 Bio (QTTB) files for 6.875M share offering by selling stockholders
- Richard Lowenthal resigns from ARS Pharmaceuticals board
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Citi, Morgan Stanley, Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share